In addition to those you listed, an interesting point is Perceptive Advisors, which was involved in - drumroll - a certain Provention Bio. That’s the same company that had that drug Tzield with unpleasant side effects and about the same efficacy… It was sold to Sanofi for three billion USD. They had at least a 7% stake in 2021. Provention Bio didn’t seem to have its own factory and numerous other strengths that Diamyd…
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| NextCell: Kantasoluilla kohti mullistusta | 56 | 5313 | March 21, 2026 | |
| Novo Nordisk - Euroopan arvokkain yhtiö? | 743 | 305004 | March 24, 2026 | |
| Prolight Diagnostics (PRLD) - Keskuslaboratorion diagnostiikkaa käden ulottuvilla | 35 | 2027 | January 30, 2026 | |
| Faron Pharmaceuticals - Innovatiivisia lääketieteen ratkaisuja (Osa 1) | 9988 | 1666811 | August 31, 2025 | |
| Pharming Group - Harvinainen tilaisuus harvinaisilla lääkkeillä | 43 | 5433 | March 26, 2026 |